The Classification of Microglial Activation Phenotypes on Neurodegeneration and Regeneration in Alzheimer's Disease Brain

Overview

Journal Arch Immunol Ther Exp (Warsz)

Publisher Sciendo

Specialty Allergy & Immunology

Date 2012 Jun 20

PMID 22710659

Citations 186

Authors

Megan M Varnum

Tsuneya Ikezu

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive decline of cognitive function. There is no therapy that can halt or reverse its progression. Contemporary research suggests that age-dependent neuroinflammatory changes may play a significant role in the decreased neurogenesis and cognitive impairments in AD. The innate immune response is characterized by pro-inflammatory (M1) activation of macrophages and subsequent production of specific cytokines, chemokines, and reactive intermediates, followed by resolution and alternative activation for anti-inflammatory signaling (M2a) and wound healing (M2c). We propose that microglial activation phenotypes are analogous to those of macrophages and that their activation plays a significant role in regulating neurogenesis in the brain. Microglia undergo a switch from an M2- to an M1-skewed activation phenotype during aging. This review will assess the neuroimmunological studies that led to characterization of the different microglial activation states in AD mouse models. It will also discuss the roles of microglial activation on neurogenesis in AD and propose anti-inflammatory molecules as exciting therapeutic targets for research. Molecules such as interleukin-4 and CD200 have proven to be important anti-inflammatory mediators in the regulation of neuroinflammation in the brain, which will be discussed in detail for their therapeutic potential.

Citing Articles

Immune Modulation in Alzheimer's Disease: From Pathogenesis to Immunotherapy.

Balkhi S, Di Spirito A, Poggi A, Mortara L Cells. 2025; 14(4).

PMID: 39996737 PMC: 11853524. DOI: 10.3390/cells14040264.

Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer's Disease.

Lee E, Chang Y Cells. 2025; 14(3).

PMID: 39936960 PMC: 11817173. DOI: 10.3390/cells14030168.

Innate and adaptive immunity in neurodegenerative disease.

Huang Y, Zhang G, Li S, Feng J, Zhang Z Cell Mol Life Sci. 2025; 82(1):68.

PMID: 39894884 PMC: 11788272. DOI: 10.1007/s00018-024-05533-4.

Role of NLRP3 Inflammasome in Chronic Pain and Alzheimer's Disease-A Review.

Moradi F, Mokhtari T J Biochem Mol Toxicol. 2025; 39(2):e70071.

PMID: 39853846 PMC: 11798427. DOI: 10.1002/jbt.70071.

3-Dimensional morphological characterization of neuroretinal microglia in Alzheimer's disease via machine learning.

Nassrallah W, Li H, Irani L, Wijesinghe P, Hogg P, Hui L Acta Neuropathol Commun. 2024; 12(1):202.

PMID: 39719599 PMC: 11669245. DOI: 10.1186/s40478-024-01898-6.

References

Lemere C, Blusztajn J, Yamaguchi H, Wisniewski T, Saido T, Selkoe D . Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis. 1996; 3(1):16-32. DOI: 10.1006/nbdi.1996.0003. View

Broderick C, Hoek R, Forrester J, Liversidge J, Sedgwick J, Dick A . Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am J Pathol. 2002; 161(5):1669-77. PMC: 1850781. DOI: 10.1016/S0002-9440(10)64444-6. View

Magavi S, Mitchell B, Szentirmai O, Carter B, Macklis J . Adult-born and preexisting olfactory granule neurons undergo distinct experience-dependent modifications of their olfactory responses in vivo. J Neurosci. 2005; 25(46):10729-39. PMC: 6725839. DOI: 10.1523/JNEUROSCI.2250-05.2005. View

Minati L, Edginton T, Bruzzone M, Giaccone G . Current concepts in Alzheimer's disease: a multidisciplinary review. Am J Alzheimers Dis Other Demen. 2009; 24(2):95-121. PMC: 10846154. DOI: 10.1177/1533317508328602. View

Copland D, Calder C, Raveney B, Nicholson L, Phillips J, Cherwinski H . Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis. Am J Pathol. 2007; 171(2):580-8. PMC: 1934542. DOI: 10.2353/ajpath.2007.070272. View

Edison P, Archer H, Gerhard A, Hinz R, Pavese N, Turkheimer F . Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol Dis. 2008; 32(3):412-9. DOI: 10.1016/j.nbd.2008.08.001. View

Tahara K, Kim H, Jin J, Maxwell J, Li L, Fukuchi K . Role of toll-like receptor signalling in Abeta uptake and clearance. Brain. 2006; 129(Pt 11):3006-19. PMC: 2445613. DOI: 10.1093/brain/awl249. View

Lund S, Christensen K, Hedtjarn M, Mortensen A, Hagberg H, Falsig J . The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and in vivo conditions. J Neuroimmunol. 2006; 180(1-2):71-87. DOI: 10.1016/j.jneuroim.2006.07.007. View

Zhang S, Cherwinski H, Sedgwick J, Phillips J . Molecular mechanisms of CD200 inhibition of mast cell activation. J Immunol. 2004; 173(11):6786-93. DOI: 10.4049/jimmunol.173.11.6786. View

10.

Lyons A, Downer E, Crotty S, Nolan Y, Mills K, Lynch M . CD200 ligand receptor interaction modulates microglial activation in vivo and in vitro: a role for IL-4. J Neurosci. 2007; 27(31):8309-13. PMC: 6673084. DOI: 10.1523/JNEUROSCI.1781-07.2007. View

11.

Li H, Hu J, Ma L, Yuan Z, Wang Y, Wang X . Comprehensive study of baicalin down-regulating NOD2 receptor expression of neurons with oxygen-glucose deprivation in vitro and cerebral ischemia-reperfusion in vivo. Eur J Pharmacol. 2010; 649(1-3):92-9. DOI: 10.1016/j.ejphar.2010.09.023. View

12.

Aizenstein H, Nebes R, Saxton J, Price J, Mathis C, Tsopelas N . Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol. 2008; 65(11):1509-17. PMC: 2636844. DOI: 10.1001/archneur.65.11.1509. View

13.

Loerch P, Lu T, Dakin K, Vann J, Isaacs A, Geula C . Evolution of the aging brain transcriptome and synaptic regulation. PLoS One. 2008; 3(10):e3329. PMC: 2553198. DOI: 10.1371/journal.pone.0003329. View

14.

Deng W, Aimone J, Gage F . New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?. Nat Rev Neurosci. 2010; 11(5):339-50. PMC: 2886712. DOI: 10.1038/nrn2822. View

15.

Boekhoorn K, Joels M, Lucassen P . Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus. Neurobiol Dis. 2006; 24(1):1-14. DOI: 10.1016/j.nbd.2006.04.017. View

16.

Wright G, Cherwinski H, Foster-Cuevas M, Brooke G, Puklavec M, Bigler M . Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J Immunol. 2003; 171(6):3034-46. DOI: 10.4049/jimmunol.171.6.3034. View

17.

Bauer J, Ganter U, Strauss S, Stadtmuller G, Frommberger U, Bauer H . The participation of interleukin-6 in the pathogenesis of Alzheimer's disease. Res Immunol. 1992; 143(6):650-7. DOI: 10.1016/0923-2494(92)80051-l. View

18.

Gutowicz M . [The influence of reactive oxygen species on the central nervous system]. Postepy Hig Med Dosw (Online). 2011; 65:104-13. DOI: 10.5604/17322693.933486. View

19.

Lambert M, Barlow A, Chromy B, Edwards C, Freed R, Liosatos M . Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A. 1998; 95(11):6448-53. PMC: 27787. DOI: 10.1073/pnas.95.11.6448. View

20.

Bernstein B, Bamburg J . Actin-ATP hydrolysis is a major energy drain for neurons. J Neurosci. 2003; 23(1):1-6. PMC: 6742122. View